Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karol E Watson

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Reviews in Cardiovascular Medicine|March 3, 2005
Novel serum markers for risk prediction in acute coronary syndromesKarol E Watson
Current Atherosclerosis Reports|March 28, 2008
What is the evidence in favor of low-dose statin therapy in 2008?Karol E Watson
Reviews in Cardiovascular Medicine|May 25, 2010
Pitavastatin: the newest HMG-CoA reductase inhibitorKarol E Watson
Reviews in Cardiovascular Medicine|April 17, 2004
The relationship between inflammation and atherosclerotic eventsKarol E Watson
Reviews in Cardiovascular Medicine|March 15, 2006
Air pollution and heart diseaseKarol E Watson
Current Cardiology Reports|October 16, 2003
Plasma lipoprotein concentrations in ethnic populationsKarol E Watson
Journal of the American Academy of Nurse Practitioners|May 31, 2008
Pathogenesis of CHD: the role of elevated triglyceridesKarol E Watson
Reviews in Cardiovascular Medicine|July 14, 2009
The JUPITER trial: How will it change clinical practice?Karol E Watson
Reviews in Cardiovascular Medicine|August 11, 2004
Cardiovascular disease in African Americans. IntroductionKarol E Watson
Journal of the National Medical Association|February 19, 2008
Cardiovascular risk reduction among African Americans: a call to actionKarol E Watson
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Reviews in Cardiovascular Medicine|March 3, 2005
Novel serum markers for risk prediction in acute coronary syndromesKarol E Watson
Current Atherosclerosis Reports|March 28, 2008
What is the evidence in favor of low-dose statin therapy in 2008?Karol E Watson
Reviews in Cardiovascular Medicine|May 25, 2010
Pitavastatin: the newest HMG-CoA reductase inhibitorKarol E Watson
Reviews in Cardiovascular Medicine|April 17, 2004
The relationship between inflammation and atherosclerotic eventsKarol E Watson
Reviews in Cardiovascular Medicine|March 15, 2006
Air pollution and heart diseaseKarol E Watson
Current Cardiology Reports|October 16, 2003
Plasma lipoprotein concentrations in ethnic populationsKarol E Watson
Journal of the American Academy of Nurse Practitioners|May 31, 2008
Pathogenesis of CHD: the role of elevated triglyceridesKarol E Watson
Reviews in Cardiovascular Medicine|July 14, 2009
The JUPITER trial: How will it change clinical practice?Karol E Watson
Reviews in Cardiovascular Medicine|August 11, 2004
Cardiovascular disease in African Americans. IntroductionKarol E Watson
Journal of the National Medical Association|February 19, 2008
Cardiovascular risk reduction among African Americans: a call to actionKarol E Watson
Pageof 18